|
1）Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism. Cell. 2010; 142: 24-38
|
|
|
|
2）植田 亮，岩井一宏．生体の鉄代謝調節メカニズム: 細胞の鉄センシングにはミトコンドリアが関与する．生化学．2007; 79: 1021-31
|
|
|
|
|
3）Zecca L, Youdim MB, Riederer P, et al. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004; 5: 863-73
|
|
|
|
|
|
4）Youdim MBH, Gerlach M, Riederer P. Iron deficiency and excess in the brain: implications for cognitive impairment and neurodegeneration. In: Yehuda S, Mostofsky DI, editors. Iron Deficiency and Overload: From Basic Biology to Clinical Medicine. New York: Humana Press; 2010
|
|
|
|
|
|
5）Gotz ME, Double K, Gerlach M, et al. The relevance of iron in the pathogenesis of Parkin-sons disease. Ann N Y Acad Sci. 2004; 1012: 193-208
|
|
|
|
|
|
6）Moos T, Rosengren Nielsen T, Skjorringe T, et al. Iron trafficking inside the brain. J Neurochem. 2007; 103: 1730-40
|
|
|
|
|
|
7）Todorich B, Pasquini JM, Garcia CI, et al. Oligodendrocytes and myelination: the role of iron. Glia. 2009; 57: 467-78
|
|
|
|
|
|
8）Erikson KM, Aschner M. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology. 2006; 27: 125-30
|
|
|
|
|
|
9）Halliwell B. Oxidative stress and neuro-degeneration: where are we now? J Neurochem. 2006; 97: 1634-58
|
|
|
|
|
|
10）Madsen E, Gitlin JD. Copper and iron disorders of the brain. Annu Rev Neurosci. 2007; 30: 317-37
|
|
|
|
|
|
11）Gregory A, Hayflick SJ. Genetics of neuro-degeneration with brain iron accumulation. Curr Neurol Neurosci Rep. 2011; 11: 254-61
|
|
|
|
|
|
12）Keogh MJ, Chinnery PF. Current concepts and controversies in neurodegeneration with brain iron accumulation. Semin Pediatr Neurol. 2012; 19: 51-6
|
|
|
|
|
|
13）Dusek P, Schneider SA. Neurodegeneration with brain iron accumulation. Curr Opin Neurol. 2012; 25: 499-506
|
|
|
|
|
|
14）Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 1995; 9: 267-72
|
|
|
|
|
|
15）Curtis ARJ, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001; 28: 350-4
|
|
|
|
|
|
16）Ohta E, Nagasaka T, Shindo K, et al. Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology. 2008; 70: 1493-4
|
|
|
|
|
|
17）Khateeb S, Flusser H, Ofir R, et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet. 2006; 79: 942-8
|
|
|
|
|
|
18）Morgan NV, Westaway SK, Morton JEV, et al. PLA2G6, encoding a phospholipase A(2), is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006; 38: 752-4
|
|
|
|
|
|
19）Edvardson S, Hama H, Shaag A, et al. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet. 2008; 83: 643-8
|
|
|
|
|
|
20）Kruer MC, Paisan-Ruiz C, Boddaert N, et al. Defective FA2H leads to a novel form of neuro-degeneration with brain iron accumulation (NBIA). Ann Neurol. 2010; 68: 611-8
|
|
|
|
|
|
21）Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009; 46: 73-80
|
|
|
|
|
|
22）Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012; 46: 1-18
|
|
|
|
|
|
23）Hartig MB, Iuso A, Haack T, et al. Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet. 2011; 89: 543-50
|
|
|
|
|
|
24）Deschauer M, Gaul C, Behrmann C, et al. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol. 2012; 259: 2434-9
|
|
|
|
|
|
25）Horvath R, Holinski-Feder E, Neeve VC, et al. A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuro-pathy. Mov Disord. 2012; 27: 789-93
|
|
|
|
|
|
26）植田 亮，浅野剛史，武田有紀子，他．細胞の鉄代謝調節機構 ミトコンドリアの新たな機能．細胞工学．2008; 27: 214-8
|
|
|
|
|
|
27）Ye H, Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry. 2010; 49: 4945-56
|
|
|
|
|
|
28）Pandolfo M. Iron and Friedreich ataxia. J Neural Transm Suppl. 2006; 143-6
|
|
|
|
|
|
29）Richardson DR, Lane DJR, Becker EM, et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A. 2010; 107: 10775-82
|
|
|
|
|
|
30）Bartzokis G, Cummings J, Perlman S, et al. Increased basal ganglia iron levels in Huntington disease. Arch Neurol. 1999; 56: 569-74
|
|
|
|
|
|
31）Drayer B, Burger P, Hurwitz B, et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol. 1987; 149: 357-63
|
|
|
|
|
|
32）Grimaud J, Millar J, Thorpe JW, et al. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1995; 59: 306-8
|
|
|
|
|
|
33）Singh A, Isaac AO, Luo X, et al. Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog. 2009; 5: e1000336
|
|
|
|
|
|
34）Kasarskis EJ, Tandon L, Lovell MA, et al. Aluminum, calcium, and iron in the spinal-cord of patients with sporadic amyotrophic-lateral-sclerosis using laser microprobe mass-spectroscopy - a preliminary-study. J Neurol Sci. 1995; 130: 203-8
|
|
|
|
|
|
35）Jeong SY, Rathore KI, Schulz K, et al. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009; 29: 610-9
|
|
|
|
|
|
36）Gaeta A, Hider RC. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol. 2005; 146: 1041-59
|
|
|
|
|
|
37）Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of beta-amyloid pre-cursor protein is inhibited by zinc in Alzheimers disease. Cell. 2010; 142: 857-67
|
|
|
|
|
|
38）Lei P, Ayton S, Finkelstein DI, et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med. 2012; 18: 291-5
|
|
|
|
|
|
39）Stankowski JN, Dawson VL, Dawson TM. Ironing out taus role in parkinsonism. Nat Med. 2012; 18: 197-8
|
|
|
|
|
|
40）Sian-Hulsmann J, Mandel S, Youdim MB, et al. The relevance of iron in the pathogenesis of Parkinsons disease. J Neurochem. 2011; 118: 939-57
|
|
|
|
|
|
41）Narendra DP, Youle RJ. Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal. 2011; 14: 1929-38
|
|
|
|
|
|
42）田中啓二，松田憲之，尾勝 圭．ミトコンドリア膜電位依存性の品質管理機構: ParkinとPINK1の役割．In: 鈴木則宏，祖父江 元，荒木信夫，他，編．Annual review 神経2012．東京: 中外医学社; 2012. p.37-42
|
|
|
|
|
|
43）Boddaert N, Le Quan Sang KH, Rotig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood. 2007; 110: 401-8
|
|
|
|
|